These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 21841463)
1. Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin II-induced cardiomyocyte hypertrophy. Chang L; Yang R; Wang M; Liu J; Wang Y; Zhang H; Li Y Am J Med Sci; 2012 Mar; 343(3):220-6. PubMed ID: 21841463 [TBL] [Abstract][Full Text] [Related]
2. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway. Yu L; Meng W; Ding J; Cheng M Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306 [TBL] [Abstract][Full Text] [Related]
3. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. D'Amore A; Black MJ; Thomas WG Hypertension; 2005 Dec; 46(6):1347-54. PubMed ID: 16286564 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183 [TBL] [Abstract][Full Text] [Related]
5. Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling. Chen Y; Yao F; Chen S; Huang H; Wu L; He J; Dong Y Pharmazie; 2014 Nov; 69(11):833-7. PubMed ID: 25985580 [TBL] [Abstract][Full Text] [Related]
6. Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Huang Q; Guo Y; Zeng H; Xie W; Yan H; Ding H Endocr Res; 2011; 36(3):93-100. PubMed ID: 21314328 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes. Jin X; Guo B; Yan J; Yang R; Chang L; Wang Y; Miao C; Liu S; Zhang H; Li Y Mol Cell Biochem; 2015 Oct; 408(1-2):215-22. PubMed ID: 26126628 [TBL] [Abstract][Full Text] [Related]
8. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255 [TBL] [Abstract][Full Text] [Related]
9. [Alteration of signal transduction-associated gene expression in rat cardiac fibroblasts induced by blocking angiotensin II receptors]. Jiang XY; Gao GD; Wang XF; Lin YX; Wang YW; Yang YB Sheng Li Xue Bao; 2006 Dec; 58(6):556-66. PubMed ID: 17173190 [TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling 3 is induced by angiotensin II in heart and isolated cardiomyocytes, and participates in desensitization. Calegari VC; Bezerra RM; Torsoni MA; Torsoni AS; Franchini KG; Saad MJ; Velloso LA Endocrinology; 2003 Oct; 144(10):4586-96. PubMed ID: 12960061 [TBL] [Abstract][Full Text] [Related]
11. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A]. Zhou DX; Liang QS; He XX; Zhan CY Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357 [TBL] [Abstract][Full Text] [Related]
12. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Carneiro-Ramos MS; Diniz GP; Nadu AP; Almeida J; Vieira RL; Santos RA; Barreto-Chaves ML Basic Res Cardiol; 2010 May; 105(3):325-35. PubMed ID: 20155476 [TBL] [Abstract][Full Text] [Related]
13. Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism. Yu L; She T; Li M; Shi C; Han L; Cheng M Int J Mol Med; 2013 Sep; 32(3):717-22. PubMed ID: 23842595 [TBL] [Abstract][Full Text] [Related]
14. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway. Liu J; Shen Q; Wu Y Life Sci; 2008 May; 82(19-20):991-6. PubMed ID: 18400235 [TBL] [Abstract][Full Text] [Related]
15. EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes. Liu Y; Shen HJ; Wang XQ; Liu HQ; Zheng LY; Luo JD J Cell Biochem; 2018 Nov; 119(10):8290-8303. PubMed ID: 29923351 [TBL] [Abstract][Full Text] [Related]
16. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes. Lyu L; Wang H; Li B; Qin Q; Qi L; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T J Mol Cell Cardiol; 2015 Dec; 89(Pt B):268-79. PubMed ID: 26497614 [TBL] [Abstract][Full Text] [Related]
17. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway. Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II upregulation of cardiomyocyte adiponectin production is nitric oxide/cyclic GMP dependent. Guo B; Li Y; Han R; Zhou H; Wang M Am J Med Sci; 2011 May; 341(5):350-5. PubMed ID: 21358315 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy. Shanmugam P; Valente AJ; Prabhu SD; Venkatesan B; Yoshida T; Delafontaine P; Chandrasekar B J Mol Cell Cardiol; 2011 Jun; 50(6):928-38. PubMed ID: 21376054 [TBL] [Abstract][Full Text] [Related]
20. Type 1 angiotensin receptor (AT1-R)-mediated decrease in type 2 angiotensin receptor mRNA level is dependent on Gq and extracellular signal-regulated kinase 1//2 in AT1-R-transfected PC12 cells. Saito M; Shinohara Y; Sasaki H; Netsu Y; Yoshida M; Nakahata N J Neuroendocrinol; 2008 Mar; 20(3):299-308. PubMed ID: 18208547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]